Search for: "Pharmaceutical Associates, Inc." Results 481 - 500 of 1,890
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jan 2016, 9:00 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
31 Dec 2015, 7:15 am by Barry Sookman
The intellectual property chapter of the Trans-Pacific Partnership (TPP) is certainly misunderstood. [read post]
30 Dec 2015, 5:58 am by Mary Jane Wilmoth
The Department of Justice announced settlements in the following False Claims Act lawsuits: United States Settles False Claims Act Suit against Guardian Hospice and Related Entities Guardian Hospice of Georgia LLC, Guardian Home Care Holdings Inc. and AccentCare Inc. [read post]
20 Dec 2015, 8:45 pm by Kevin LaCroix
Instead, the new lawsuit relates to a company called KaloBios Pharmaceuticals, Inc. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
2 Dec 2015, 12:38 pm by Schachtman
Metabolife Int’l, Inc., 401 F.3d 1233, 1241 (11th Cir. 2005) (reversing admission of expert witness’s testimony when the witness conceded a dose-response, but failed to address the dose of the medication needed to cause the claimed harm). [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
18 Nov 2015, 5:06 am
App. 2011)), or set up an administration system for a prescription drug at an individual patient’s residence (San Antonio Extended Medical Care, Inc. v. [read post]
17 Nov 2015, 5:07 am by Grimes Teich Anderson LLP
Recent articles in Forbes Magazine and The Wall Street Journal reported that Janssen Pharmaceuticals, Inc., which is a Johnson & Johnson company, has been accused of a failure to warn about the side effect. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
"] The findings are contrary to data presented [in "New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO®", a press release from Janssen Pharmaceuticals, Inc.] on the safety of [Xarelto (rivaroxaban)] in 39,052 people with NVAF showed the rates and patterns of major bleeding in routine clinical practice were 2.89 per 100 person-years. [read post]
17 Oct 2015, 10:01 pm by Dan Flynn
A couple dozen of the nation’s top business lawyers from such powerful organizations as the National Association of Manufacturers, The Cato Institute, Chamber of Commerce of the United States, Washington Legal Foundation, and the Pharmaceutical Research and Manufacturers of America have all waded into Appellate Case: 15-1890 in the U.S. [read post]
16 Sep 2015, 4:31 pm by Nancy E. Halpern, DVM, Esq.
As reported by VCA ANTECH INC, in its annual report filed 03/01/13 for the period ending 12/31/12: According to American Pet Products Association, Inc. [read post]
16 Sep 2015, 12:59 pm by Hollis Wright
 Complex litigation against large pharmaceutical companies demands specialized legal experience. [read post]
8 Sep 2015, 1:15 pm by Tom Lamb
Given these numerous case reports made to Health Canada and documented in medical articles, one wonders whether the responsible drug company, Janssen Pharmaceuticals, Inc., should increase the drug label warnings about hepatic / liver side effects such as acute liver failure, which can be fatal in some instances. [read post]